ArticleFrontiers in drug delivery2026

Case report: Caplacizumab without plasma exchange for severe thrombotic thrombocytopenic purpura.

Sarah Maryon Hayes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.